Preclinical studies have demonstrated that depletion of macrophages significantly increases CD8+ T‐cell infiltration into tumor islets, thereby improving the efficacy of anti‐PD‐1/PD‐L1 treatment [5]. The gene discussed is CD8A; the disease is neoplasm.